British Journal of Pharmacology | 2021

M351‐0056 is a novel low MW compound modulating the actions of the immune‐checkpoint protein VISTA

 
 
 
 
 
 
 

Abstract


The protein V‐domain immunoglobulin suppressor of T‐cell activation (VISTA) is a novel immune‐checkpoint molecule that belongs to the B7 family and regulates a broad spectrum of immune responses. So far, low MW compounds targeting VISTA for the treatment of autoimmune diseases or inflammation, have not been identified.

Volume 178
Pages 1445 - 1458
DOI 10.1111/bph.15357
Language English
Journal British Journal of Pharmacology

Full Text